Cargando…
Global COVID‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system
PURPOSE: To describe the characteristics of adverse event reporting in the United States (US) Food and Drug Administration Adverse Event Reporting System (FAERS) before and after the outbreak of the COVID‐19 pandemic. METHODS: We included all FAERS reports from the US and Canada from November 7, 201...
Autores principales: | Dörks, Michael, Jobski, Kathrin, Hoffmann, Falk, Douros, Antonios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012989/ https://www.ncbi.nlm.nih.gov/pubmed/33650210 http://dx.doi.org/10.1002/pds.5217 |
Ejemplares similares
-
Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis
por: Dörks, Michael, et al.
Publicado: (2021) -
Combined use of drugs inhibiting the renin–angiotensin system: prescribing patterns and risk of acute kidney injury in German nursing home residents
por: Dörks, Michael, et al.
Publicado: (2018) -
Regional Differences in Opioid Prescribing in Germany – Results of an Analysis of Health Insurance Data of 57 Million Adult People
por: Jobski, Kathrin, et al.
Publicado: (2020) -
Nurse-Filled versus Pharmacy-Filled Medication Organization Devices—Survey on Current Practices and Views of Home Care Nursing Services
por: Schmid, Thomas, et al.
Publicado: (2022) -
Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe
por: Jobski, Kathrin, et al.
Publicado: (2022)